AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$12.24
-3.28%
Mkt Cap $3.48B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
Implied Upside
-38.7%
Consensus $7.50 vs current $12.24
NASDAQ·Healthcare·Biotechnology
$12.24
-3.28%
Mkt Cap $3.48B
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
-38.7%
Consensus $7.50 vs current $12.24